# A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

> **NCT00696826** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 20 (actual)

## Conditions studied

- Liver Insufficiency

## Interventions

- **DRUG:** sitagliptin phosphate

## Key facts

- **NCT ID:** NCT00696826
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696826, "A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)". Retrieved via MORVS 2026-10-29 from https://api.morvs.ai/clinical/NCT00696826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*